Kura Oncology, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 7.93 M | $69.11 M | 10.88% | 9.12% |
ARMISTICE CAPITAL, LLC | 02/14/2025 | 5.80 M | $50.52 M | 118.21% | 6.67% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 5.08 M | $44.22 M | -33.67% | 5.84% |
VANGUARD GROUP INC | 02/11/2025 | 4.82 M | $41.97 M | 14.64% | 5.54% |
RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 4.45 M | $38.77 M | 100.00% | 5.12% |
ECOR1 CAPITAL, LLC | 02/14/2025 | 3.56 M | $30.98 M | -38.74% | 4.09% |
BVF INC/IL | 02/14/2025 | 2.57 M | $22.36 M | -23.85% | 2.95% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 2.37 M | $20.62 M | 180.07% | 2.72% |
AVORO CAPITAL ADVISORS LLC | 02/14/2025 | 2.25 M | $19.60 M | -36.47% | 2.59% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.78 M | $15.53 M | 0.09% | 2.05% |
FORESITE CAPITAL MANAGEMENT IV, LLC | 02/14/2025 | 1.73 M | $15.04 M | -6.65% | 1.99% |
FRANKLIN RESOURCES INC | 02/12/2025 | 1.54 M | $13.40 M | -3.14% | 1.77% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 1.43 M | $12.42 M | 35.32% | 1.64% |
TCG CROSSOVER MANAGEMENT, LLC | 02/14/2025 | 1.42 M | $12.40 M | 0.00% | 1.64% |
SIREN, L.L.C. | 02/14/2025 | 1.34 M | $11.67 M | 0.00% | 1.54% |
PROSIGHT MANAGEMENT, LP | 02/14/2025 | 1.33 M | $11.54 M | 87.91% | 1.52% |
D. E. SHAW & CO., INC. | 02/14/2025 | 1.15 M | $10.03 M | 172.02% | 1.32% |
QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 1.12 M | $9.72 M | 982.52% | 1.28% |
MARSHALL WACE, LLP | 02/13/2025 | 948,905 | $8.26 M | 100.00% | 1.09% |
ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 905,184 | $7.88 M | -13.96% | 1.04% |
ALGERT GLOBAL LLC | 02/14/2025 | 883,703 | $7.70 M | 224.56% | 1.02% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 863,085 | $7.52 M | 21.65% | 0.99% |
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 02/12/2025 | 694,387 | $6.05 M | 100.00% | 0.80% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 635,494 | $5.54 M | 1.69% | 0.73% |
SPHERA FUNDS MANAGEMENT LTD. | 02/14/2025 | 610,087 | $5.31 M | 0.00% | 0.70% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 597,810 | $5.21 M | 463.39% | 0.69% |
TREXQUANT INVESTMENT LP | 02/12/2025 | 566,945 | $4.94 M | 867.76% | 0.65% |
ALETHEA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 558,442 | $4.86 M | 0.89% | 0.64% |
WALLEYE CAPITAL LLC | 02/13/2025 | 536,318 | $4.67 M | -6.13% | 0.62% |
DAFNA CAPITAL MANAGEMENT LLC | 02/14/2025 | 448,368 | $3.91 M | 9.80% | 0.52% |
CANDRIAM S.C.A. | 02/07/2025 | 422,652 | $3.68 M | -53.37% | 0.49% |
JPMORGAN CHASE & CO | 02/12/2025 | 365,921 | $3.19 M | -10.59% | 0.42% |
1492 CAPITAL MANAGEMENT LLC | 02/13/2025 | 342,598 | $2.98 M | 367.88% | 0.39% |
UBS GROUP AG | 02/14/2025 | 315,475 | $2.75 M | 143.02% | 0.36% |
RHENMAN & PARTNERS ASSET MANAGEMENT AB | 02/13/2025 | 314,526 | $2.74 M | 88.88% | 0.36% |
RUSSELL INVESTMENTS GROUP, LTD. | 02/13/2025 | 298,662 | $2.60 M | 18.16% | 0.34% |
EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/12/2025 | 297,234 | $2.59 M | 440.71% | 0.34% |
VOSS CAPITAL, LLC | 02/13/2025 | 275,000 | $2.40 M | 100.00% | 0.32% |
TWO SIGMA ADVISERS, LP | 02/14/2025 | 242,200 | $2.11 M | 147.15% | 0.28% |
JUMP FINANCIAL, LLC | 02/13/2025 | 239,933 | $2.09 M | 862.04% | 0.28% |
HOLOCENE ADVISORS, LP | 02/14/2025 | 226,895 | $1.98 M | -91.56% | 0.26% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 202,941 | $1.77 M | -1.33% | 0.23% |
BARCLAYS PLC | 02/13/2025 | 201,864 | $1.76 M | 21.98% | 0.23% |
FMR LLC | 02/13/2025 | 184,428 | $1.61 M | 113.38% | 0.21% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 182,668 | $1.59 M | -28.89% | 0.21% |
WOODLINE PARTNERS LP | 02/14/2025 | 172,704 | $1.50 M | 20.60% | 0.20% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 166,119 | $1.45 M | -20.23% | 0.19% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 163,559 | $1.42 M | 969.92% | 0.19% |
SUPERSTRING CAPITAL MANAGEMENT LP | 02/14/2025 | 157,959 | $1.38 M | 100.00% | 0.18% |
VELAN CAPITAL INVESTMENT MANAGEMENT LP | 02/14/2025 | 150,000 | $1.31 M | 100.00% | 0.17% |
Kura Oncology, Inc. institutional Ownership - FAQ's
During the previous two years, 246 institutional investors and hedge funds held shares of Kura Oncology, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 7.93 M
ARMISTICE CAPITAL, LLC: 5.8 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 5.08 M
VANGUARD GROUP INC: 4.82 M
RA CAPITAL MANAGEMENT, L.P.: 4.45 M
EcoR1 Capital, LLC: 3.56 M
90.77% of Kura Oncology, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 82.66 M shares in the last 24 months. This purchase volume represents approximately $703.47 M in transactions.